DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

NCT06178159 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Disitamab Vedotin Injection
DRUG: Pertuzumab Injection
DRUG: Toripalimab

Sponsor

RemeGen Co., Ltd.